<bill session="116" type="s" number="3343" updated="2022-02-08T23:22:58Z">
  <state datetime="2020-02-27">REFERRED</state>
  <status>
    <introduced datetime="2020-02-27"/>
  </status>
  <introduced datetime="2020-02-27"/>
  <titles>
    <title type="display">Medical Supply Chain Security Act</title>
    <title type="short" as="introduced">Medical Supply Chain Security Act</title>
    <title type="official" as="introduced">A bill to amend the Federal Food, Drug, and Cosmetic Act to provide enhanced security for the medical supply chain.</title>
  </titles>
  <sponsor bioguide_id="H001089"/>
  <cosponsors>
    <cosponsor bioguide_id="M000934" joined="2020-05-04"/>
  </cosponsors>
  <actions>
    <action datetime="2020-02-27">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2020-02-27" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSHR" name="Senate Health, Education, Labor, and Pensions" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="116" type="h" number="6049" relation="identical"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Congressional oversight"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Health information and medical records"/>
    <term name="Health technology, devices, supplies"/>
    <term name="Manufacturing"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary date="2021-09-07T20:59:00Z" status="Introduced in Senate">Medical Supply Chain Security Act

This bill requires manufacturers of essential medical devices (i.e., those that are life supporting, life-sustaining, or intended for use for a debilitating disease or condition) to notify the Food and Drug Administration (FDA) if the device is discontinued or if there is any meaningful disruption to the device's manufacturing. The bill also authorizes the FDA to expedite review of such a device to mitigate or prevent a shortage.</summary>
</bill>
